The Future of Pancreatic Cancer Treatments
Just eight percent of people with pancreatic cancer live for five years after their diagnosis. Why is this cancer so deadly and where are advances… Read More »The Future of Pancreatic Cancer Treatments
Issues & Perspectives
Immune Checkpoint Inhibitor Therapy Guideline Continues to Draw Readers
A guideline on guide the clinical practice of managing adverse events in patients treated with immune checkpoint inhibitor (ICPi) therapy continues to draw readers nearly… Read More »Immune Checkpoint Inhibitor Therapy Guideline Continues to Draw Readers
Jaffee looks to the future of checkpoint immunotherapy for cancer treatment
Combinations strategies involving checkpoint immunotherapies were approved as first-line options in two cancer types and showed promise in clinical trials for several hard-to-treat cancers. Important… Read More »Jaffee looks to the future of checkpoint immunotherapy for cancer treatment
Three Minutes with Oncologist Michael Carducci
Michael Carducci, M.D., is the associate cancer center director for clinical research within the Johns Hopkins Kimmel Cancer Center and the regional research director for… Read More »Three Minutes with Oncologist Michael Carducci
Benefits of Immunotherapy in Metastatic Non-Small Cell Lung Cancer
Julie Brahmer, M.D., is an active clinical leader in the treatment of lung cancer and mesothelioma. As the director of the Thoracic Oncology Program and… Read More »Benefits of Immunotherapy in Metastatic Non-Small Cell Lung Cancer
Washington Post Cancer Summit: A Silent Epidemic: The rise of HPV-related cancers
Akila Viswanathan, M.D., executive vice chair of Johns Hopkins Radiation Oncology and Molecular Radiation Sciences, was part of a panel discussion on the rise of… Read More »Washington Post Cancer Summit: A Silent Epidemic: The rise of HPV-related cancers
Why Do People Get Cancer?
Adult cancers tend to be a little different from childhood cancers, and trying to explain the disease to a young person adds to the separation.… Read More »Why Do People Get Cancer?
Conversation With Dr. Claire Snyder About Ensuring Cancer Patients Get Best Care Possible
“During my nearly 20 years as a cancer researcher, I have always been impressed by how both my oncology and primary care colleagues don’t just… Read More »Conversation With Dr. Claire Snyder About Ensuring Cancer Patients Get Best Care Possible
Radiation Oncology Pioneer Moody Wharam, M.D., Dies at 77
Moody Wharam Jr., Professor Emeritus of Radiation Oncology and Molecular Radiation Sciences and former Willard and Lillian Hackerman Professor of Radiation Oncology at the Johns… Read More »Radiation Oncology Pioneer Moody Wharam, M.D., Dies at 77
A Look Inside the Kimmel Cancer Center’s Cancer Medicine Cabinet
Read the latest issue of Promise & Progress featuring research advances in cancer drug discovery and development, promising new cancer drugs, patient stories and more.… Read More »A Look Inside the Kimmel Cancer Center’s Cancer Medicine Cabinet